It is never too late to be recognized - and justly so - for a discovery that has benefited all mankind. Dr. Luc Montagnier has been a dominant force in both conducting and influencing research on the leading edge of preventative medicine. I am proud to be associated with both Professor Montagnier and this amazing organization that supports his work.
Houston, TX (PRWEB) October 6, 2008
Today, the Board of Directors of the Friends of the World Foundation for AIDS Research and Prevention joins people everywhere in the world in celebrating the receipt of the Nobel Prize by the organization's President, Professor Luc Montagnier.
Speaking on behalf of the Board, attorney and civic leader, Barbara Radnofsky, Secretary-Treasurer of the Friends' Board said, "This is a wonderful recognition of Professor Montagnier's earlier work. Just as importantly, the Nobel is a great boost for his current scientific research efforts. His Houston laboratory and clinic, being done in collaboration with the distinguished Houston physician, Dr. Joseph Varon, holds great promise for identifying effective treatment for a wide variety of disorders, from neurological diseases and Alzheimer's to autism and breast cancer."
The international humanitarian, benefactress and society leader, Lynn Wyatt, Special Advisor to the organization said, "It is never too late to be recognized - and justly so - for a discovery that has benefited all mankind. Dr. Luc Montagnier has been a dominant force in both conducting and influencing research on the leading edge of preventative medicine. I am proud to be associated with both Professor Montagnier and this amazing organization that supports his work."
George Marshall Worthington, Executive Director, of the Friends of the World Foundation noted, "As colleagues of Professor Montagnier, we sincerely acknowledge Professor Montagnier's co-recipients, Harald zur Hausen, recognized for his discovery of human papilloma viruses causing cervical cancer and Françoise Barré-Sinoussi who the Nobel Committee recognized along with Professor Montagnier for their discovery of the human immunodeficiency virus. Our organization joins in celebrating this recognition of these outstanding medical researchers and their steadfast commitment to the welfare of humanity."
In celebrating the award of the Nobel Prize to Professor Luc Montagnier, the Board noted that he is a world-renowned medical researcher who has devoted his life to developing solutions for the most important health challenges of our times. Besides his involvement in the design of new types of protective and therapeutic AIDS vaccines, his current studies are aimed at the diagnosis and treatment of analogous microbial and viral factors associated with cancers, neuro-degenerative and auto-immune diseases such as Alzheimer's. A strong advocate of preventative medicine, Professor Montagnier is especially concerned with prolonging the active life of aging people. His extensive research interests and scientific expertise parallel his deep commitment to helping developing countries acquire knowledge of and access to both state-of-the-art preventative and curative medicine.
Among Professor Montagnier's achievements - recognized by the Nobel Committee - is the isolation, with his French team, of the viruses causing AIDS (HIV1 and HIV2). His research included seminal observations concerning the role of oxidative stress and infectious co-factors in the destruction of the immune system of HIV-infected patients. As President of the World Foundation for AIDS Research and Prevention he co-founded two centers for the treatment, research and diagnosis of AIDS patients in Cote d'Ivoire and Cameroon. He is supervising the creation of similar centers throughout Africa. In collaboration with Joseph Varon, M.D., he recently inaugurated a new clinical research center in Houston.
The World Foundation is a 501(c)(3) Houston-based charity established to provide leadership in developing resources to sponsor and fund the projects of Professor Montagnier as well as other research aimed at the design of new types of protective and therapeutic AIDS vaccines, prolonging the active life of aging people and the diagnosis and treatment of microbial and viral factors associated with cancers of the breast and other organs, neurodegenerative, auto-immune and other multi-factorial disease processes such as Autism, Alzheimer's and Parkinson's.
For further information on the subject of this release or to arrange interviews with any of the individuals above, contact George Marshall Worthington, Executive Director, at 713.256.8965 or worthworldtx @ sprintmail.com. The address of the organization is 2323 McDuffie, Houston, Texas 77019-6527.